AARTI DRUGS
Back to Cashflow Statement
|
AARTI DRUGS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹254 Cr | ₹245 Cr | ₹359 Cr | ₹133 Cr | ₹70 Cr |
What is the latest Cash Flow from Operating Activities ratio of AARTI DRUGS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹254 Cr |
| Mar2025 | ₹245 Cr |
| Mar2024 | ₹359 Cr |
| Mar2023 | ₹133 Cr |
| Mar2022 | ₹70 Cr |
How is Cash Flow from Operating Activities of AARTI DRUGS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹254 Cr | 3.66 | |
| Mar2025 | ₹245 Cr | -31.86 | |
| Mar2024 | ₹359 Cr | 169.22 | |
| Mar2023 | ₹133 Cr | 89.34 | |
| Mar2022 | ₹70 Cr | - | |
Compare Cash Flow from Operating Activities of peers of AARTI DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI DRUGS | ₹3,466.7 Cr | -4.9% | -13% | -27.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -0.1% | -6.5% | 3.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹240,780.0 Cr | -0.2% | -5.5% | 35.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,828.0 Cr | 0.4% | -8.2% | 25.2% | Stock Analytics | |
| CIPLA | ₹109,305.0 Cr | 1.7% | -2% | -15.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,759.0 Cr | 4.9% | 7.7% | -2.5% | Stock Analytics | |
AARTI DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI DRUGS | -4.9% |
-13% |
-27.8% |
| SENSEX | -1.5% |
-1.2% |
-11.8% |
You may also like the below Video Courses